Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

OMC · Q4 2025 Earnings

Omnicom Group

Reported February 18, 2026

30-second summary

Omnicom's first combined-entity print delivered $5.53B revenue (+27.9% YoY) and $2.59 non-GAAP EPS, with a $941M GAAP net loss driven by acquisition-related charges. Underneath the GAAP noise, management disclosed Q4 organic growth of approximately 4% on a retained-portfolio basis (12 months Omnicom + 1 month IPG, excluding planned dispositions) — a clean acceleration from the 3% YTD pace. The real news is everywhere except the operating line: synergy targets doubled from $750M to $1.5B (with $900M landing in 2026), the board authorized a $5.0B buyback with $2.5B launched as an ASR, and management announced it will retire the organic growth metric from 2026 quarterly disclosures while deferring detailed 2026 guidance to a March 12 investor day. The narrative pivot from organic operator to integration/capital-return story is complete — and management is asking investors to underwrite it before showing the 2026 P&L math.

Headline numbers

EPS

Q4 FY2025

$2.59

Revenue

Q4 FY2025

$5.53B

+27.9% YoY

Operating margin

Q4 FY2025

-17.7%

Key financials

Q4 FY2025

Metric	Q4 FY2025	YoY	Q3 FY2025	QoQ
Revenue	$5.53B	+27.9%	$4.04B	+36.9%
EPS	$2.59	—	$2.24	+15.6%
Operating margin	-17.7%	—	13.1%	-3080bps

Guidance

Company dramatically raised capital return plans with $5.0B buyback authorization (vs $600M FY2025 guidance) and doubled cost synergy targets to $1.5B; FY2025 guidance items withdrawn as period now reported with 10.1% YoY revenue growth.

Guidance is issued for both next quarter and the full year. Both may appear below.

New guidance

Metric	Period	Guide	YoY
Cost synergies target	FY 2026	$1.5 billion total, $900 million in 2026	—
Net interest expense increase	FY 2026	approximately $210 million	—
Share repurchase program	FY 2026	$5.0 billion authorization, $2.5 billion ASR launched	—
Share count reduction	FY 2026	9% to 11% reduction by end of 2026; 7% to 8% weighted average reduction	—
Expected FX benefit	FY 2026	in excess of 2% revenue benefit	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
2025 organic growth	FY 2025	Approximately 3%	Withdrawn — no replacement	—	Withdrawn
2025 adjusted EBITDA margin	FY 2025	10 basis points higher than full year 2024 results of 15.5% (i.e., ~15.6%)	Withdrawn — no replacement	—	Withdrawn
2025 adjusted income tax rate	FY 2025	Between 26.5% and 27%	Withdrawn — no replacement	—	Withdrawn
2025 share repurchase	FY 2025	Close to $600 million	Withdrawn — no replacement	—	Withdrawn

Platform metrics

Q4 FY2025

Segment	Q4 FY2025
Cost Synergy Target	$1.5 billion total; $900 million in 2026

Profitability

Q4 FY2025

Segment	Q4 FY2025
Adjusted EBITA Margin	16.8%
Full Year Adjusted EBITA Margin	15.6%

Other KPIs

Q4 FY2025

Segment	Q4 FY2025
Share Buyback Authorization	$5.0 billion ($2.5 billion ASR)

Management tone

Q1 2025 IPG announcement → Q2 2025 defensive floor-protection → Q3 2025 forward-leaning on AI + synergy upside → Q4 2025 transformation & capital return

Synergies went from "deliver $750M" to "exceed $750M" to "$1.5B over 30 months, $900M in 2026" in two quarters. Last quarter management refused to size the upside in Q&A; this quarter they doubled it. From the press release: "we now expect our annual run rate synergies to double from our initial estimate of $750 million to $1.5 billion over the next 30 months. We expect to achieve $900 million of these savings in 2026." The signal is twofold — first, the integration teams found materially more cost out than the deal model assumed (or were always going to claim more once close was done); second, the front-loaded $900M in 2026 is what the new EPS bridge requires given the $210M interest expense headwind and lost revenue from $3.2B of repositioned operations.

The deal narrative shifted from "two companies integrating" to "merged operating model" in 11 weeks post-close. Throughout 2025 management framed integration as careful, multi-quarter, respecting IPG independence. This quarter: "we treated it as a merger... We formed a combined platform organization... we went in with five global network brands and we decided that we'd be best served by going forward with 30 brands." Brand consolidation of that magnitude this early is aggressive and indicates either higher confidence in integration execution or higher urgency to extract synergies than the original $750M figure implied. Probably both.

Organic growth disclosure is being de-emphasized rather than fully retired. Q2 2025 was framed as floor-defense at 3% organic. Q3 reaffirmed the 2.5–4.5% range. This quarter management said the historical organic growth slide won't appear in 2026 quarterly presentations — but they did volunteer a Q4 retained-portfolio organic figure of approximately 4% (12 months Omnicom + 1 month IPG, excluding planned dispositions), per Phil Angelostro: "Had we calculated organic growth consistent with our prior practice, excluding planned dispositions and assets held for sale, organic growth in Q4 2025 would have been approximately 4%." The reframe is that organic growth will be reported on the retained-portfolio base going forward rather than the legacy base — which both removes the divested-business drag and removes a directly-comparable peer benchmark. Combined with the deferred 2026 revenue guidance, investors will need the investor day to see how this new base will be presented quarterly.

AI narrative consolidated from "fastest growing platform" (Q3) to capability multiplier (Q4). Last quarter's escalation positioned AI as a platform; this quarter's framing is operational: "our teams can now test 20 concepts, can test 50 concepts... It's not necessarily about how do we reduce the number of people around us. It's really about increasing the impact and output that we're driving for our clients." The shift moves AI risk away from agency-margin compression and toward higher-value delivery — useful narrative ahead of a March investor day where the new combined-entity growth algorithm will need to be sold.

Capital return became the primary value-creation lever. For three quarters of 2025 the buyback was capped at $600M by the merger agreement; 2025 actual spend was $708M. This quarter the cap came off and the response was a $5.0B authorization with a $2.5B ASR launched immediately plus a planned additional $500M–$1B of opens-market repurchases in 2026 — roughly 4–5x the 2025 deployment level for the 2026 year. With weighted average shares falling 7–8% in 2026, EPS gets a mechanical lift regardless of revenue trajectory. The capital allocation regime has changed from "preserve cash for deal close" to "aggressively shrink the float."

Recurring themes management leaned on this quarter:

Integration execution and pace accelerationPortfolio simplification and strategic repositioningSynergy realization (labor, real estate, G&A)AI-driven capability enhancement and output multiplicationClient momentum and new business winsCapital allocation through aggressive buyback ($2.5B ASR initiated)

Risks management surfaced:

Execution risk on $1.5B synergy target across 30-month timeframeFX headwinds if recent rates don't persist (benefited 2% in Q4, expecting 2%+ in 2026)Interest expense increase of $210M in 2026 from IPG debt assumption and refinancingUncertainty in 2026 planning completion and detailed guidance deferralClient negotiation dynamics as AI changes pricing and performance models

Answers to last quarter's watch list

IPG close completion and Day-1 financial disclosure — IPG close completed and reflected in Q4 results (partial quarter, +27.9% reported revenue YoY). Management announced the doubled $1.5B synergy target and disclosed the $210M YoY interest expense headwind from acquisition debt. Detailed 2026 revenue and EBITDA guidance was deferred from a previously suggested earlier window to the March 12 investor day.

Resolved positively

Precision Marketing recovery from +0.8% — combined-entity Q4 Precision Marketing revenue printed at $570M but organic growth was not disclosed at the discipline level under the new reporting framework. The underlying question — whether the Q3 Credera consulting weakness was idiosyncratic or structural — remains unanswered.

Not resolved

Q4 organic growth above 3% to defend the FY range midpoint — Q4 retained-portfolio organic growth was ~4% (12 months Omnicom + 1 month IPG, excluding planned dispositions), per management's disclosure on the call. That beats the 3% YTD pace and clears the bar implied by the original FY 2.5–4.5% range, though the basis (retained portfolio rather than legacy comparable) is non-standard. Status: Resolved positively (with caveat on basis)

Net interest expense run-rate — management quantified the 2026 step-up at approximately $210M vs 2025, materially worse than the Q3 trajectory implied and a hard drag on 2026 EPS that the $900M of in-year synergies will need to offset. The pro forma debt burden is real and disclosed.

Resolved negatively

Combined entity organic growth disclosure framework — the historical organic growth slide will not appear in 2026 quarterly presentations, but management is willing to disclose retained-portfolio organic growth on request (as evidenced by the Q4 4% figure). Combined with the $3.2B portfolio repositioning program and deferred 2026 guidance, the 2026 reporting framework is being rebuilt around synergies, margins, and EPS, with organic growth as a secondary metric on the new retained base. Status: Partially resolved

Asia Pacific trajectory — Q4 combined-entity APAC revenue was $591M but standalone organic growth was not disclosed at the regional level. Management called out France, the Netherlands, and China as Q4 weak spots and Latin America as strong. The geographic disclosure granularity from Q3 (where APAC printed -3.7% organic) is no longer comparable under the new combined-entity reporting.

Not resolved

What to watch into next quarter

March 12 investor day — does management quantify a 2026 revenue and EBITDA range? The decision to defer detailed guidance from the Q4 print to the March event was framed as planning incomplete. If the investor day delivers concrete ranges (revenue dollar guide, EBITDA margin, EPS algorithm), the narrative is intact; if it delivers another set of qualitative directional statements anchored to synergies and share count, the deferral pattern itself becomes the concern.

$900M synergy capture pace in H1 2026 — $900M of in-year savings on a 30-month $1.5B run-rate target requires front-loaded execution. Watch Q1 SG&A and salary-related cost ratios. A first-quarter run-rate that doesn't show meaningful sequential cost compression makes the $900M number aspirational rather than tracking.

Pace of $3.2B revenue repositioning program — management committed to completing the $2.5B non-strategic exits within 12 months, with ~$800M already done. The disclosure cadence (whether divested revenue is segregated in quarterly results, the proceeds, the gain/loss recognition) will determine whether 2026 underlying performance can be tracked at all. The separate ~$700M majority-to-minority transition will also affect reported revenue without being a true exit.

ASR settlement and remaining buyback execution — $2.5B ASR launched at close means an interim share count delivery and final true-up later in 2026, plus $500M–$1B of additional repurchases planned during 2026. Watch for the ASR settlement timing and whether the post-2026 ~$1.5–$2B of remaining authorization is deployed on a programmatic or opportunistic basis. The 9–11% end-of-year share count reduction target is contingent on full deployment.

Whether retained-portfolio organic growth becomes a standing disclosure — management disclosed the Q4 ~4% figure on a non-standard basis and signaled the legacy slide is being retired. If the retained-portfolio metric becomes a recurring quarterly figure, comparability is partially preserved; if it's only disclosed when convenient, peer benchmarking against Publicis and WPP becomes materially harder.

Net interest expense trajectory vs the $210M guide — the $210M YoY increase is the hardest 2026 EPS headwind and rests on refinancing assumptions for the $1.4B April 2026 maturity (4.07% book rate) plus commercial paper borrowings for the ASR. Q1 interest expense run-rate annualized will indicate whether the $210M is conservative, accurate, or already at risk of expansion.

Sources

Omnicom Group Q4 2025 Earnings Release, filed with the SEC: https://www.sec.gov/Archives/edgar/data/29989/000002998926000002/a2025q4earningsrelease.htm
Omnicom Group Q4 2025 earnings call — prepared remarks and Q&A session with John Wren (CEO), Phil Angelostro (CFO), and Paolo (platform commentary), with analyst questions from Stephen Cahill (Wells Fargo), David Karnofsky (JPMorgan), Thomas Yeh (Morgan Stanley), Jason, Nicholas Langley (BNP), Michael Nathanson (MoffettNathanson), and Tom Nolan (SSR).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.